EDGAR Filing Documents for 0000000000-17-015889

Form UPLOAD - SEC-generated letter:

SEC Accession No. 0000000000-17-015889

Filing Date

2017-05-05

Accepted

2017-05-05 15:37:06

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.pdf	LETTER	30438
	Complete submission text file	0000000000-17-015889.txt		42769

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406

Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 6108166640

Nabriva Therapeutics Plc (Filed for) CIK: 0001703287 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations